NCT03467581 Five-year Outcome of Laparoscopic Gastric Sleeve
| NCT ID | NCT03467581 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tartu University Hospital |
| Condition | Bariatric Surgeries |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2008-10-08 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2008-10-08 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the long-term (5-year follow-up) results of laparoscopic gastric sleeve (LGS) in terms of weight loss and obesity related comorbidities, as well as the risk factors associated with postoperative nutritional deficiencies.
Eligibility Criteria
Inclusion Criteria: * The criteria for bariatric surgery: BMI of \>40, or \>35 with certain obesity related comorbidities Exclusion Criteria: * Patients who did not fill the inclusion criteria
Contact & Investigator
Toomas Sillakivi, Dr, PhD
✉ toomas.sillakivi@kliinikum.eeFrequently Asked Questions
Who can join the NCT03467581 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Bariatric Surgeries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03467581 currently recruiting?
Yes, NCT03467581 is actively recruiting participants. Contact the research team at toomas.sillakivi@kliinikum.ee for enrollment information.
Where is the NCT03467581 trial being conducted?
This trial is being conducted at Tartu, Estonia.
Who is sponsoring the NCT03467581 clinical trial?
NCT03467581 is sponsored by Tartu University Hospital. The trial plans to enroll 500 participants.